Главная
Study mode:
on
1
Intro
2
Lung Cancer Incidence
3
Chemotherapy
4
Stage 3 Lung Cancer
5
New Directions in Lung Cancer
6
Stage 4 Lung Cancer
7
New chemotherapies
8
Avastin
9
Maintenance treatment
10
Angiogenesis switch
11
Antibodies
12
Targeted drugs
13
Avastin and Cetuximab
14
Gene pathways
15
Types of CAN services
16
ROS1 mutation
17
Other mutations
18
Alch mutation
19
What is a targeted drug
20
Lung cancer trials
21
Fine needle aspiration
22
Collaboration
23
Targeted Therapy
24
Tumor Markers
25
PT Skin
26
Communitybased practice
27
Clinical trials of targeted drugs
28
Biopsy options
29
Rise in nonsmokers lung cancer
30
Intervention for nonsmokers
31
Screening for lung cancer
32
Clinical trials for lung cancer
33
How are patients volunteer tumor pieces collected
Description:
Explore the latest advancements in lung cancer care with UCLA oncologist Dr. Anita Kaul in this comprehensive 58-minute lecture. Delve into the evaluation and treatment of various lung cancer types, focusing on how systemic treatments are evolving based on molecular profiles. Gain insights into lung cancer incidence, chemotherapy approaches, and the management of different stages of the disease. Discover new directions in lung cancer treatment, including targeted therapies, immunotherapies, and the role of clinical trials. Learn about the importance of tumor markers, biopsy options, and the rise of lung cancer in non-smokers. Understand the significance of screening and early intervention, as well as the process of collecting volunteer tumor samples for research. This informative presentation offers valuable knowledge for healthcare professionals, patients, and anyone interested in the latest developments in lung cancer care.

New Directions in Lung Cancer Care - Anita Kaul, MD - UCLA Health

University of California, Los Angeles
Add to list
0:00 / 0:00